AWM
WST icon

Activest Wealth Management’s West Pharmaceutical WST Stock Holding History

Activest Wealth Management’s Portfolio WST Stock Details WST Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$10.8K Sell
30
-15
-33% -$4.59K ﹤0.01% 564
2026
Q1 		$11.3K Sell
45
-40
-47% -$9.95K ﹤0.01% 656
2025
Q4 		$23.4K Buy
85
+31
+57% +$8.48K ﹤0.01% 472
2025
Q3 		$14.2K Sell
54
-7
-11% -$1.7K ﹤0.01% 427
2025
Q2 		$13.3K Buy
+61
New +$13K ﹤0.01% 383
2025
Q1 		– Sell
-1
Closed -$276 – 1181
2024
Q4 		$328 Buy
+1
New +$315 ﹤0.01% 581

Other funds holding WST

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Artisan Partners
Artisan Partners Milwaukee, Wisconsin $63.1B AUM 35.51% 1-Year Est. Return
Bank of New York Mellon
Bank of New York Mellon New York $609B AUM 40.19% 1-Year Est. Return
GIM
Generation Investment Management London, United Kingdom $10.3B AUM 4.84% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
T. Rowe Price Investment Management
T. Rowe Price Investment Management Baltimore, Maryland $153B AUM 38.14% 1-Year Est. Return

Activest Wealth Management's WST Position: Q2 2026 in Review

Activest Wealth Management reduced its West Pharmaceutical (WST) stake by 33% in Q2 2026, selling an estimated $4.59K and leaving 30 shares worth $10.8K. The position accounts for ﹤0.01% of the portfolio, ranked #564.

Activest Wealth Management first reported a position in WST in Q4 2024 and has held it in 6 quarters since. The position peaked at $23.4K in Q4 2025. 832 funds tracked by Wall St. Rank hold WST as of Q2 2026.

  • Activest Wealth Management held 30 shares of West Pharmaceutical worth $10.8K as of Q2 2026.
  • Activest Wealth Management sold 15 West Pharmaceutical shares in Q2 2026, an estimated $4.59K.
  • West Pharmaceutical made up ﹤0.01% of Activest Wealth Management's portfolio in Q2 2026, its #564 holding.
  • Activest Wealth Management first reported a position in West Pharmaceutical in Q4 2024 and has held it in 6 quarters since.
  • Activest Wealth Management's West Pharmaceutical position peaked at $23.4K in Q4 2025.
  • 832 funds tracked by Wall St. Rank held West Pharmaceutical as of Q2 2026.

Based on Activest Wealth Management's 13F filing for Q2 2026, filed 16 Jul 2026.